Weight loss drugs and muscle loss: a growing concern The introductions of semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound, Mounjaro) have revolutionized healthcare, but physicians are finding that patients often lose a significant portion of their lean muscle mass while on the medications
We observed that more than one-third of metabolites detected in heart were significantly altered with aging, which was predominantly characterized by a rise in the level of glycerophospholids, and to a lesser extent, acylcarnitines (Fig
Macronutrient, Micronutrient Supplementation and Monitoring for Patients on GLP-1 Agonists: Can We Learn from Metabolic and Bariatric Surgery
Peptides are also sensitive to light
As a dad juggling it all, this is your chance to feel more energized, confident, and in control
Our provider collaboration features include: Comprehensive PDF reports that can be shared directly with your provider before appointments Medication adherence summaries showing your consistency with the prescribed regimen Side effect timelines that help providers make informed decisions about dosage adjustments Progress visualizations that highlight improvements across multiple health metrics Appointment reminders for follow-up visits and monitoring These detailed reports often lead to more productive appointments, as your provider can quickly understand your experience and make data-informed treatment adjustments